These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20876507)

  • 1. The economic case for new stroke thrombolytics.
    Johnston SC
    Stroke; 2010 Oct; 41(10 Suppl):S59-62. PubMed ID: 20876507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?
    Soeteman DI; Menzies NA; Pandya A
    Value Health; 2017; 20(7):894-901. PubMed ID: 28712618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM; Guzauskas GF; Chen E; Lalla D; Tayama D; Fagan SC; Veenstra DL
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
    Demaerschalk BM; Yip TR
    Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
    Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
    PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
    Earnshaw SR; Jackson D; Farkouh R; Schwamm L
    Stroke; 2009 May; 40(5):1710-20. PubMed ID: 19286581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran.
    Amiri A; Goudarzi R; Amiresmaili M; Iranmanesh F
    J Med Econ; 2018 Mar; 21(3):282-287. PubMed ID: 29105528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of thrombolytic treatment for stroke.
    Mar J; Begiristain JM; Arrazola A
    Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspective.
    Jackson D; Earnshaw SR; Farkouh R; Schwamm L
    AJNR Am J Neuroradiol; 2010 Oct; 31(9):1669-74. PubMed ID: 20538823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
    Kalish SC; Gurwitz JH; Krumholz HM; Avorn J
    J Gen Intern Med; 1995 Jun; 10(6):321-30. PubMed ID: 7562123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke.
    Moodie ML; Carter R; Mihalopoulos C; Thrift AG; Chambers BR; Donnan GA; Dewey HM
    Stroke; 2004 May; 35(5):1041-6. PubMed ID: 15031457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.
    Magnuson EA; Chinnakondepalli K; Vilain K; Kearon C; Julian JA; Kahn SR; Goldhaber SZ; Jaff MR; Kindzelski AL; Herman K; Brady PS; Sharma K; Black CM; Vedantham S; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2019 Oct; 12(10):e005659. PubMed ID: 31592728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
    Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
    Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.